Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2026-09-02 20:22:18 ET · period of report 2026-08-31 · accession 0000874015-26-000259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 20:22 | 2026-08-31 | IONS | Birchler Brian | EVP, Corp, Development Ops | J - Other | $51.31 | +58 | 102.9K | +0.1% | +$2,976 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | J | A | 58 | $51.31 | 102,883 | D | — | — | (F1) Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2026. These shares may not be sold until February 28, 2027. |